From: HIV prevention research and COVID-19: putting ethics guidance to the test
Number | Summary |
---|---|
1 | Those engaged in HIV prevention research must be committed to designing and implementing high-quality scientific research and research ethics practices throughout the research process |
2 | HIV prevention research should prioritize efforts that address public health needs, reduce health inequities, and are locally relevant |
3 | Relevant communities should be actively engaged throughout the research process to help ensure that HIV prevention research is appropriate as well as scientifically and ethically sound |
4 | HIV prevention research should seek to develop local capacity and establish collaborative partnerships |
5 | HIV prevention research should be designed to minimize risks and maximize benefits to study participants and their communities, while remaining scientifically sound |
6 | Each site involved in HIV prevention research should develop, implement, and document appropriate informed consent, assent, permission, and re-consent processes tailored to the needs of participants |
7 | HIV prevention researchers should assess, monitor, and respond to the social, cultural and other factors that may place research participants at heightened risk |
8 | Independent ethics review committees in host countries should review HIV prevention research |
9 | HIV prevention researchers should partner with key stakeholders to provide a package of effective, comprehensive, and sustainable prevention services to all participants in HIV prevention research |
10 | HIV prevention researchers should strive to provide care and treatment to participants that exceed local standards of medical services yet does not impose undue influence to participate in research |
11 | HIV prevention researchers and sponsors should ensure that appropriate mechanisms for independent data and safety monitoring are in place |
12 | HIV prevention researchers should plan for the timely communication of HIV prevention research results to scientific audience as well as participants, affected communities, and other stakeholders in a manner that promotes understanding and trust |
13 | HIV prevention researchers should endeavor to ensure that the investments made in developing capacity will continue to provide benefits and opportunities for local researchers and communities after research ends |
14 | HIV prevention researchers should seek to facilitate continuity of prevention services and care for participants who still require it after research participation has ended |
15 | HIV prevention research seeking to establish the efficacy of an intervention must have at minimum a preliminary plan regarding post-trial access to interventions proven to be safe and effective, which offer meaningful benefit for research participants and their communities |